Epcoritamab + R (2) regimen and responses in high-risk follicular lymphoma, regardless of POD24 status Meeting Abstract
| Authors: | Merryman, R.; Belada, D.; Sureda, A.; Leppä, S.; Vermaat, J. S. P.; Holte, H.; Hutchings, M.; Lugtenburg, P.; de Vos, S.; Abrisqueta, P.; Nijland, M.; Christensen, J. H.; Wahlin, B. E.; Linton, K. M.; Wang, L.; Abbas, A.; Rana, A.; Quadri, S.; Falchi, L. |
| Abstract Title: | Epcoritamab + R (2) regimen and responses in high-risk follicular lymphoma, regardless of POD24 status |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.7506 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting abstract: 7506 -- Meeting also presented virtually -- Source: Cinahl |
